<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Pulmonary <z:e sem="disease" ids="C0043541" disease_type="Disease or Syndrome" abbrv="">zygomycosis</z:e> is an uncommon <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> that occurs mostly in immunocompromised patients </plain></SENT>
<SENT sid="1" pm="."><plain>We report the case of a 75-year-old man with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, treated with lenalidomide for 3 months, who developed <z:hpo ids='HP_0002093'>respiratory failure</z:hpo> and a <z:hpo ids='HP_0003678'>rapidly progressive</z:hpo> left upper lobe consolidation </plain></SENT>
<SENT sid="2" pm="."><plain>An extensive workup was unrevealing of the etiology, and the patient expired </plain></SENT>
<SENT sid="3" pm="."><plain>A full autopsy was declined, but an in situ post-mortem transbronchial lung biopsy revealed pulmonary <z:e sem="disease" ids="C0043541" disease_type="Disease or Syndrome" abbrv="">zygomycosis</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>This unique case illustrates the potential risks of lenalidomide therapy in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and the difficulties in diagnosing pulmonary <z:e sem="disease" ids="C0043541" disease_type="Disease or Syndrome" abbrv="">zygomycosis</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>To our knowledge this is the first report of a diagnostic in situ post-mortem transbronchial lung biopsy </plain></SENT>
</text></document>